INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/11/2025
Voltar para busca
Dado oficial do USPTO
LUNAPHORE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LUNAPHORE
ST13
US500000079179383Classe
5, 9, 10
Pedido
79179383
Registro
5361858
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
71
Atualização mais recente
08/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
06/11/2015
Data de registro
26/12/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/09/2024
Última transação
08/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Tolochenaz, CH
Examinador
HENRY,NAKIA D
Localização atual
Historical data usage
Titulares e representantes
Titulares
Lunaphore Technologies SA
Lunaphore Technologies SA
Representantes
Courtney Thompson Fredrikson & Byron, P.A.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic substancespreparations and agents for medical purposes; diagnostic reagents and contrast media for medical purposes; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical purposes; diagnostic test reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids ; biotechnological preparations for medical purposes for the treatment of cancer and metabolic diseases
Classe 9
Scientific apparatus and instrumentselectronic analyzers for testing and analyzing chemical and biological substances for the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms; optical apparatus and instrumentsmicroscopesoptical profilersoptical filtersoptical glassesoptical lens sightsoptical scannersoptical readersoptical reflectors; weighing apparatus and instrumentsscales and balances; measuring apparatus and instrumentsinstruments for measuring the quantity of contaminantspollutantsmalignant cells in humananimalplantmicroorganism cells and tissues; signaling apparatus and instrumentssignal processorssignal splitters for electronic apparatus; measuring and testing machines and instrumentsdigitizers; laboratory apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; microfluidic testing apparatus not for medical purposes in the form of assay chipsbiological assay chipssample processing chips; microfluidic systemssample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubesreservoirspumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidicsnot for medical purposes used to diagnose cancer; chipsintegrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chipsmicrochips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatusinstruments and devicescalculating machinescentral processing units and computers for the inputoutputtransmissionstorageprocessing of datain particular scientific and medical data; Software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms collected via immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing
Classe 10
Medical apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; medical apparatus and instruments for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing using fluid technology; diagnostic apparatus for medical purpose; microfluidic testing apparatus for medical purposes for testing biomarker expression levels in cell and tissue samples
Publicações
Histórico de despachos e eventos da marca no USPTO.
71 publicações encontradas
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21/09/2025
INPC
INVALIDATION PROCESSED
20/09/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/06/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
18/05/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
18/09/2024
71AG
REGISTERED-SEC.71 ACCEPTED
18/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/09/2024
ES71
TEAS SECTION 71 RECEIVED
22/12/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/07/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/11/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/05/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/04/2018
FIMP
FINAL DISPOSITION PROCESSED
02/04/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
26/12/2017
GPNX
NOTIFICATION PROCESSED BY IB
17/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2017
PUBO
PUBLISHED FOR OPPOSITION
10/10/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/09/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/09/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/09/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/08/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
15/08/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/08/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
15/08/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/08/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/07/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/06/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/06/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
14/04/2017
GNFR
FINAL REFUSAL E-MAILED
14/04/2017
CNFR
FINAL REFUSAL WRITTEN
14/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/03/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/09/2016
GNRT
NON-FINAL ACTION E-MAILED
26/09/2016
CNRT
NON-FINAL ACTION WRITTEN
26/09/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
26/09/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/09/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2016
ALIE
ASSIGNED TO LIE
02/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/08/2016
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
18/08/2016
RFNT
REFUSAL PROCESSED BY IB
26/03/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/03/2016
RFRR
REFUSAL PROCESSED BY MPU
08/03/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/03/2016
CNRT
NON-FINAL ACTION WRITTEN
04/03/2016
DOCK
ASSIGNED TO EXAMINER
01/03/2016
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
22/01/2016
MAFR
APPLICATION FILING RECEIPT MAILED
05/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/12/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/12/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LUNAPHORE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.